Lv1
60 积分 2024-01-08 加入
Brain-shuttle biologics chart new paths across the blood–brain barrier
20小时前
待确认
Post-Conjugation Process for Antibody-Conjugated Lipid Nanoparticles Enabling Tunable Antibody Surface Density for Targeted RNA Delivery
4天前
已完结
Bispecific antibodies
4天前
已完结
Engineering bispecific antibodies for brain delivery of biotherapeutics in multiple species
10天前
已关闭
Research progress and development strategies of antibody-oligonucleotide conjugates
21天前
已完结
Efficient generation of epitope-targeted antibodies with Germinal
24天前
已完结
Engineered cells as programmable mRNA delivery vehicles
2个月前
已完结
Minimal residual disease (MRD)-negative outcomes following a novel, in vivo gene therapy generating anti–B-cell maturation antigen (BCMA) chimeric antigen receptor (CAR)-T cells in patients with relapsed and refractory multiple myeloma (RRMM): Preliminary results from inMMyCAR, the first-in-human phase 1 study of KLN-1010
2个月前
已完结
Target identification and assessment in the era of AI
2个月前
已完结
皖公网安备34019202002308
